KR102907590B1 - 동적 인간 중쇄 항체 라이브러리 - Google Patents

동적 인간 중쇄 항체 라이브러리

Info

Publication number
KR102907590B1
KR102907590B1 KR1020247022149A KR20247022149A KR102907590B1 KR 102907590 B1 KR102907590 B1 KR 102907590B1 KR 1020247022149 A KR1020247022149 A KR 1020247022149A KR 20247022149 A KR20247022149 A KR 20247022149A KR 102907590 B1 KR102907590 B1 KR 102907590B1
Authority
KR
South Korea
Prior art keywords
hvr
amino acid
acid sequence
seq
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020247022149A
Other languages
English (en)
Korean (ko)
Other versions
KR20240110891A (ko
Inventor
피터 페이치 루오
얀 리
팡용 두
Original Assignee
아다진 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아다진 인크. filed Critical 아다진 인크.
Publication of KR20240110891A publication Critical patent/KR20240110891A/ko
Application granted granted Critical
Publication of KR102907590B1 publication Critical patent/KR102907590B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/04—Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020247022149A 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리 Active KR102907590B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020207007876A KR20200038996A (ko) 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리
PCT/CN2017/098299 WO2019036842A1 (en) 2017-08-21 2017-08-21 DYNAMIC LIBRARIES OF HUMAN HEAVY CHAIN ANTIBODIES

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020207007876A Division KR20200038996A (ko) 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리

Publications (2)

Publication Number Publication Date
KR20240110891A KR20240110891A (ko) 2024-07-16
KR102907590B1 true KR102907590B1 (ko) 2026-01-05

Family

ID=65438261

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020247022149A Active KR102907590B1 (ko) 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리
KR1020207007876A Ceased KR20200038996A (ko) 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020207007876A Ceased KR20200038996A (ko) 2017-08-21 2017-08-21 동적 인간 중쇄 항체 라이브러리

Country Status (12)

Country Link
US (3) US11578426B2 (cg-RX-API-DMAC7.html)
EP (1) EP3673101A4 (cg-RX-API-DMAC7.html)
JP (3) JP2020537632A (cg-RX-API-DMAC7.html)
KR (2) KR102907590B1 (cg-RX-API-DMAC7.html)
CN (1) CN111279024B (cg-RX-API-DMAC7.html)
AU (1) AU2017428737B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020003622A2 (cg-RX-API-DMAC7.html)
CA (1) CA3072143A1 (cg-RX-API-DMAC7.html)
IL (1) IL272696B2 (cg-RX-API-DMAC7.html)
SG (1) SG11202001551YA (cg-RX-API-DMAC7.html)
WO (1) WO2019036842A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202001114B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202001549UA (en) 2017-08-21 2020-03-30 Adagene Inc Dynamic human antibody light chain libraries
CN111511762B (zh) 2017-08-21 2025-05-06 天演药业公司 抗cd137分子及其用途
AU2017428737B2 (en) 2017-08-21 2024-02-15 Adagene Inc. Dynamic human heavy chain antibody libraries
WO2019148444A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Anti-ctla4 antibodies and methods of making and using the same
WO2019148445A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same
CN114835811B (zh) * 2019-12-24 2024-03-26 宝船生物医药科技(上海)有限公司 抗csf1r分子及其用途
US11834512B2 (en) 2020-05-04 2023-12-05 The Regents Of The University Of California Inhibiting anti-ENPP1 antibodies
EP4225786A2 (en) * 2020-10-07 2023-08-16 Amgen Inc. Rational selection of building blocks for the assembly of multispecific antibodies
WO2023193239A1 (en) * 2022-04-08 2023-10-12 Peter Peizhi Luo Anti-cd28 antibodies and methods of use thereof
KR20260026665A (ko) 2024-08-20 2026-02-27 엘지디스플레이 주식회사 표시 장치

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013534130A (ja) * 2010-07-16 2013-09-02 アディマブ, エルエルシー 抗体ライブラリー
WO2016062989A1 (en) * 2014-10-22 2016-04-28 Crescendo Biologics Limited Human vh domain scaffolds

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
DE4002897A1 (de) * 1990-02-01 1991-08-08 Behringwerke Ag Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken")
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US20030036092A1 (en) 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5866344A (en) 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP1972194A1 (en) 1996-12-03 2008-09-24 Amgen Fremont Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
DE60224720D1 (en) 2001-11-22 2008-03-06 Univ Keio Re
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
CA2608058C (en) 2005-05-12 2013-09-10 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
EP1957531B1 (en) 2005-11-07 2016-04-13 Genentech, Inc. Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
JP5425180B2 (ja) 2008-03-27 2014-02-26 ザイモジェネティクス, インコーポレイテッド PDGFRβおよびVEGF−Aを阻害するための組成物および方法
WO2012023053A2 (en) 2010-08-16 2012-02-23 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
CN105247050B (zh) 2013-03-14 2020-06-16 天演药业 用于文库构建、亲和力结合剂筛选和其表达的整合系统
CN103603057B (zh) 2013-07-03 2016-01-06 深圳大学 基于可感染病毒颗粒型抗体重链库/轻链库的抗体筛选和制备方法
EP4477269A3 (en) 2015-09-20 2025-03-19 The United States of America, as Represented By the Secretary, Department of Health and Human Services Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use
AU2017428737B2 (en) 2017-08-21 2024-02-15 Adagene Inc. Dynamic human heavy chain antibody libraries
SG11202001549UA (en) 2017-08-21 2020-03-30 Adagene Inc Dynamic human antibody light chain libraries

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013534130A (ja) * 2010-07-16 2013-09-02 アディマブ, エルエルシー 抗体ライブラリー
WO2016062989A1 (en) * 2014-10-22 2016-04-28 Crescendo Biologics Limited Human vh domain scaffolds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chingwei V. Lee et al., ‘High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold’, J. Mol. Biol, Vol. 340, pp. 1073-1093, 2004.*
Sachdev S. Sidhu et al., ‘Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions’, J. Mol. Biol., Vol. 338, pp. 299-310, 2004.*

Also Published As

Publication number Publication date
JP2024178314A (ja) 2024-12-24
NZ761783A (en) 2025-11-28
IL272696B1 (en) 2024-09-01
ZA202001114B (en) 2024-06-26
SG11202001551YA (en) 2020-03-30
KR20240110891A (ko) 2024-07-16
JP7856719B2 (ja) 2026-05-11
JP2023025026A (ja) 2023-02-21
US11578426B2 (en) 2023-02-14
US12385162B2 (en) 2025-08-12
EP3673101A1 (en) 2020-07-01
AU2017428737B2 (en) 2024-02-15
US20200248336A1 (en) 2020-08-06
IL272696A (en) 2020-04-30
EP3673101A4 (en) 2021-03-24
CN111279024B (zh) 2024-07-19
JP2020537632A (ja) 2020-12-24
AU2017428737A8 (en) 2020-03-12
US20260146368A1 (en) 2026-05-28
US20240240358A1 (en) 2024-07-18
WO2019036842A1 (en) 2019-02-28
AU2017428737A1 (en) 2020-03-05
CN111279024A (zh) 2020-06-12
BR112020003622A2 (pt) 2020-09-01
IL272696B2 (en) 2025-01-01
KR20200038996A (ko) 2020-04-14
CA3072143A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
JP7856719B2 (ja) ダイナミックヒト重鎖抗体ライブラリー
US20230287597A1 (en) Dynamic human antibody light chain libraries
CA2572917C (en) Look-through mutagenesis for developing altered polypeptides with enhanced properties
US20190002558A1 (en) Compositions and methods for the identification and isolation of cell-membrane protein specific binding moieties
Vellalore Maruthachalam NEXT-GENERATION SEQUENCING AND MOTIF GRAFTING APPLICATIONS IN SYNTHETIC ANTIBODY DISCOVERY
Tiller Synthetic Antibodies

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)